Medical University of South Carolina Hematology-Oncology Division — Charleston, South Carolina

Medical University of South Carolina Hematology-Oncology Division is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Medical University of South Carolina Hematology-Oncology Division has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charleston

Browse all research sites in South Carolina · View every site in Charleston

• Duplicate_Medical University of South Carolina /ID# 228067
• Ralph H. Johnson Department of Veterans Affairs Medical Center
• Duplicate_Medical University of South Carolina /ID# 221072
• Medical University of South Carolina (MUSC) - Hollings Cancer Center
• Medical University of South Carolina /ID# 265113
• Medical University of South Carolina Weight Management Center
• Medical University South Carolina Hospitals and Clinics
• Medical University of South Carolina Children Hospital - PIN
• Addiction Sciences Division-Medical University of South Carolina
• Medical University of South Carolina Infectious Disease Clinic
• Medical University of South Carolina (MUSC) - College of Medicine (COM)

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical University of South Carolina Hematology-Oncology Division?

Medical University of South Carolina Hematology-Oncology Division has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical University of South Carolina Hematology-Oncology Division conducted?

Medical University of South Carolina Hematology-Oncology Division has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Is Medical University of South Carolina Hematology-Oncology Division accredited by Crixeo Clinical Trials?

Medical University of South Carolina Hematology-Oncology Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical University of South Carolina Hematology-Oncology Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.